Position in ZTS
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$472
-$1,243 QoQ
Shares Held
4
-63.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Silicon Valley Capital Partners holds $21,325 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (2.2% of the industry book) .
All Filings in ZTS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $472 | 4 | Shares | Sole | 2026-05-19 | |
| 2025-06-30 | $1,715 | 11 | Shares | Sole | 2025-09-11 | |
| 2024-12-31 | $9,938 | 61 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $11,918 | 61 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $10,574 | 61 | Shares | Sole | 2024-10-30 | |
| 2024-03-31 | $10,152 | 60 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $11,842 | 60 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,438 | 60 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $10,332 | 60 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||